Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pegylated liposome simoctocog alfa - Ascension Healthcare

Next Previous
Drug Profile

Pegylated liposome simoctocog alfa - Ascension Healthcare

Alternative Names: FVIII-PEGLip; PBB 8 IN; PEGLip-FVIII; PEGylated liposome simoctocog alfa; SelectAte; TheraPEG™ FVIII; XLR 8

Latest Information Update: 18 Dec 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Celtic Pharma; PolyTherics
  • Developer Ascension Healthcare
  • Class Antihaemorrhagics; Blood coagulation factors; Coagulants; Polyethylene glycols; Recombinant fusion proteins
  • Mechanism of Action Factor VIII replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Haemophilia A

Most Recent Events

  • 18 Dec 2022 Preclinical trials in Haemophilia A in United Kingdom (SC) (Ascension pipeline, December 2022)
  • 12 Dec 2022 Efficacy data from a phase II trial in Haemophilia A presented at the 64th Annual Meeting of American Society of Hematology (ASH-2022)
  • 12 Dec 2022 Efficacy data from a phase II trial in Haemophilia A presented at the 64th American Society of Hematology Annual Meeting(ASH-2022)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top